The global non-animal softgel capsule market size was valued at USD 583.7 million in 2021 and is poised to grow at a significant CAGR of 7.2% during the forecast period 2022-28. Sports nutrition is being practiced by more than just competitive athletes and weightlifters. Global events, marathons, and sporting events have brought sports into the public eye. Additionally, as interest in fitness and body image has grown, businesses have been forced to reposition themselves as suppliers of products for a healthy lifestyle. More consumers are predicted to be interested in health awareness than professional athletes. As a result, sports nutrition is getting more shelf space in supermarkets. This enables manufacturers of sports supplements to offer sports nutrition products such as soft gel capsules for oral administration to a broad consumer base worldwide.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/non-animal-softgel-capsules-market/

Pharmaceuticals Segment to Dominate the Non-Animal Softgel Capsule Market
The pharmaceuticals segment is expected to account for a larger revenue share in the global non-animal softgel capsule market, with a value share worldwide. It is projected to grow at a 7.9% CAGR between 2022 and 2028. In the global non-animal soft gel capsules market, the pharmaceuticals segment is anticipated to expand due to softgels' ability to mask odors, elegant appearance, and simplicity of consumption. Furthermore, these formulations are considered the best since they support the bioavailability and absorption of essential nutrients. Vitamin and mineral supplements are the most often used starch softgel health supplements. Additionally, it is anticipated that increased use of sports-related health nutritional supplements and expanding public awareness of the advantages of exercise and good health will fuel the segment's growth.

The global non-animal softgel capsule market is segmentation:

  • By Material Type: Starch, Carrageenan-Starch Blends, and Others
  • By Application: Pharmaceuticals, Healthcare Supplements, Others

Europe Non-Animal Softgel Capsule Market
The Europe market is expected to increase in the global non-animal softgel capsule market over the forecast period. It is projected to grow at a CAGR of 7.5% in the coming years. in Europe, Germany is projected to make a substantial contribution because of the rise in chronic disease incidence and increased market participant investment. For instance, in April 2019, Catalent expanded its full turnkey softgel capabilities at its facility in Eberbach, Germany. The company spent $14 million on this expansion, which includes two new soft gel encapsulation lines for its Vegicaps technology.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=56621

Key players’ profiles in the non-animal softgel capsule market report are Capsugel, Amway, Patheon, Catalent, Procaps Laboratorios, Eurocaps, Best Formulations, Aenova, Captek, SIRIO, Capsugel, and Robinson Pharma.

 

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

 

Contact:

Mr. Satya

Precision Business Insights | Toll Free: +1 866 598 1553

Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747